Essential Insights on Vale – Top 5 Key Points

It hasn't been a great morning session for Vale investors, who have watched their shares sink by -2.4% to a price of $8.96. Some of you might be wondering if it's time to buy the dip. If you are considering this, make sure to check the company's fundamentals first to determine if the shares are fairly valued at today's prices.

Vale Is Potentially Undervalued and Trades Below Its Fair Value:

Vale S.A., together with its subsidiaries, produces and sells iron ore, iron ore pellets, nickel, and copper in Brazil and internationally. The company belongs to the Basic Materials sector, which has an average price to earnings (P/E) ratio of 24.53 and an average price to book (P/B) ratio of 2.64. In contrast, Vale has a trailing 12 month P/E ratio of 4.2 and a P/B ratio of 0.18.

Vale has moved -39.5% over the last year compared to 28.8% for the S&P 500 — a difference of -68.2%. Vale has a 52 week high of $16.08 and a 52 week low of $8.96.

Wider Gross Margins Than the Industry Average of 30.62%:

2018 2019 2020 2021 2022 2023
Revenue (M) $36,575 $36,549 $39,545 $54,502 $43,839 $41,784
Gross Margins 40% 47% 56% 60% 45% 42%
Net Margins 19% -5% 12% 41% 43% 19%
Net Income (M) $6,860 -$1,683 $4,881 $22,445 $18,788 $7,983
Net Interest Expense (M) -$4,957 -$3,393 -$4,813 $3,119 $2,268 -$1,946
Depreciation & Amort. (M) $3,211 $3,503 $1,254 -$3,962 $1,309 $1,428
Diluted Shares (M) 5,126 5,126 5,130 4,840 4,779 4,539
Earnings Per Share $1.34 -$0.33 $0.95 $4.47 $3.93 $1.76
Free Cash Flow (M) $9,117 $8,406 $9,892 $20,646 $13,316 $11,332
CAPEX (M) $3,784 $3,704 $4,430 $5,033 $5,446 $5,920
Current Ratio 1.68 1.23 1.67 1.47 1.12 1.28

Vale has generally positive cash flows, slight revenue growth and increasing reinvestment in the business, and wider gross margins than its peer group. Furthermore, Vale has just enough current assets to cover current liabilities, as shown by its current ratio of 1.28.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS